ResearcherAmerican University of Beirut Medical CenterActive in the last 2 years
Walid Ghazi Faraj
Matched on ORCID iD 0000-0002-0156-7960; OpenAlex author ID A5022825960. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Markers in Resectable Pancreatic Cancer: A … Co-author DOI 10.1002/cnr2.70565↗
- Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1111/ajco.13775↗
- Prevalence of Insomnia among Pancreatic Cancer Patients following Pancreaticoduodenectomy. Last author DOI 10.1155/2021/5535220↗
- CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction between the tumors and their surrounding mic… Last author DOI 10.1016/j.heliyon.2020.e03842↗
- Modified GTX as second-line therapy for advanced pancreatic adenocarcinoma. Co-author DOI 10.1007/s12029-013-9571-x↗
- Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma. Co-author PMID 23112885↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ali I. Shamseddine · 5 shared papers, 2012–2026 · strength 0.55
- Paper Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Mar… DOI 10.1002/cnr2.70565↗
- Paper Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.1111/ajco.13775↗
- Paper CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction betw… DOI 10.1016/j.heliyon.2020.e03842↗
- Sally Naji Temraz · 4 shared papers, 2012–2026 · strength 0.45
- Paper Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Mar… DOI 10.1002/cnr2.70565↗
- Paper Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.1111/ajco.13775↗
- Paper Modified GTX as second-line therapy for advanced pancreatic adenocarcinoma. DOI 10.1007/s12029-013-9571-x↗
- Ahmad Machmouchi · 1 shared paper, 2026 · strength 0.24
- Laudy Chehade · 1 shared paper, 2026 · strength 0.24
- Noura Abbas · 1 shared paper, 2026 · strength 0.24
- Ghassan K. Abou‐Alfa · 2 shared papers, 2012–2022 · strength 0.17
- Eileen Mary O'Reilly · 2 shared papers, 2012–2022 · strength 0.17
- Haifa Dbouk · 1 shared paper, 2022 · strength 0.14
- Fadi Farhat · 1 shared paper, 2022 · strength 0.14
- Sabine Chalhoub · 1 shared paper, 2021 · strength 0.14
- Wassim G. Abou-Kheir · 1 shared paper, 2020 · strength 0.10
- Hana Ajouz · 1 shared paper, 2014 · strength 0.04
- Alexandra Snyder · 1 shared paper, 2012 · strength 0.03
- David Paul Kelsen · 1 shared paper, 2012 · strength 0.03
- Leonard B. Saltz · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.